Home/ Stocks/ ICU

SeaStar Medical Holding Corporation Common Stock

ICU XNAS

$2.24 +0.06 (+2.71%) ▲ 15-min delayed

Open

$2.25

High

$2.27

Low

$2.07

Volume

177.3K

Market Cap

$8.40M

About SeaStar Medical Holding Corporation Common Stock

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 18 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$183.0K	$-3,472,000	$-0.13
Q1 2025	$293.0K	$-3,772,000	$-0.44
FY 2024	$135.0K	$-24,830,000	$-6.63
Q3 2024	$68.0K	$-4,478,000	$-1.10

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for ICU yet. Check out our latest market news or earnings calendar.

Get ICU Alerts

Stay ahead with breaking news, price alerts, and expert analysis on SeaStar Medical Holding Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.